ID   OCI-P5x
AC   CVCL_DH18
SY   OCIP5X
DR   ATCC; CRL-3552
DR   cancercelllines; CVCL_DH18
DR   DepMap; ACH-001370
DR   ECACC; 20012005
DR   GEO; GSM1001414
DR   GEO; GSM1001451
DR   GEO; GSM1001457
DR   Progenetix; CVCL_DH18
DR   Wikidata; Q54931795
RX   PubMed=26080861;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (DepMap=ACH-001370).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr236Asn (c.706T>A); ClinVar=VCV000376694; Zygosity=Unspecified (PubMed=26080861; DepMap=ACH-001370).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
ST   Source(s): DepMap=ACH-001370; PubMed=26080861
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11
ST   D16S539: 11
ST   D18S51: 15
ST   D21S11: 29
ST   D3S1358: 14
ST   D5S818: 10,12
ST   D7S820: 12
ST   D8S1179: 12,13,15
ST   FGA: 20,24
ST   Penta D: 10
ST   Penta E: 7,11
ST   TH01: 6
ST   TPOX: 9,11
ST   vWA: 14,17
DI   NCIt; C7550; Ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 14
//
RX   PubMed=26080861; DOI=10.1038/ncomms8419; PMCID=PMC4473807;
RA   Ince T.A., Sousa A.D., Jones M.A., Harrell J.C., Agoston E.S.,
RA   Krohn M., Selfors L.M., Liu W.-B., Chen K., Yong M., Buchwald P.,
RA   Wang B., Hale K.S., Cohick E., Sergent P., Witt A., Kozhekbaeva Z.M.,
RA   Gao S.-Z., Agoston A.T., Merritt M.A., Foster R., Rueda B.R., Crum C.P.,
RA   Brugge J.S., Mills G.B.;
RT   "Characterization of twenty-five ovarian tumour cell lines that
RT   phenocopy primary tumours.";
RL   Nat. Commun. 6:7419.1-7419.14(2015).
//